Characterization of Cryopreserved Plucked Hair Follicles and Generation of Functional Cell Lines for Disease Modeling and Cell Replacement Therapies
Launched by ACORN BIOLABS INC. · Jan 3, 2025
Trial Information
Current as of September 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how we can use cells from plucked hair follicles to help understand and treat diseases. Researchers will collect hair follicles, freeze them, and then grow cells from these follicles to see if they can be used in therapies for various health conditions. The goal is to learn more about these special cells and how they can be helpful in medicine.
To participate in this trial, you need to be between 18 and 80 years old, and you should be able to read and understand English. You’ll also need to agree to provide written consent to take part in the study. However, if you have any active scalp infections, inflammatory skin conditions, or chronic illnesses like autoimmune diseases or diabetes, you may not be eligible to join. If you do participate, you can expect to be involved in activities that help researchers learn more about these hair follicle cells and their potential uses in treating diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gender: Male or Female.
- • Age: ≥18 and ≤80 years.
- • Language proficiency: Able to read and understand English.
- • Informed consent: Willing to provide written, informed consent to participate in all study activities.
- Exclusion Criteria:
- • Scalp/Hair Disorders: Subjects diagnosed with active scalp infections or inflammatory skin conditions.
- • Systemic Conditions: Subjects with chronic illnesses, such as autoimmune diseases or diabetes, that may impact scalp health or wound healing.
- • Medications: Subjects on immunosuppressants, steroids, or other medications associated with hair loss.
About Acorn Biolabs Inc.
Acorn Biolabs Inc. is a pioneering biotechnology company focused on advancing personalized health solutions through the preservation and analysis of biological materials. With a commitment to empowering individuals in their health journeys, Acorn Biolabs specializes in innovative biobanking techniques that facilitate the storage of stem cells and other vital biological samples. The company’s research initiatives aim to enhance regenerative medicine and therapeutic applications, positioning Acorn Biolabs at the forefront of transformative healthcare. Through its rigorous clinical trials and collaborations with leading research institutions, Acorn Biolabs seeks to drive significant advancements in personalized medicine, ultimately improving patient outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported